↓ Skip to main content

Phenytoin versus Leviteracetam for Seizure Prophylaxis after brain injury – a meta analysis

Overview of attention for article published in BMC Neurology, May 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter
7 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
66 Dimensions

Readers on

mendeley
132 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Phenytoin versus Leviteracetam for Seizure Prophylaxis after brain injury – a meta analysis
Published in
BMC Neurology, May 2012
DOI 10.1186/1471-2377-12-30
Pubmed ID
Authors

Syed Nabeel Zafar, Abdul Ahad Khan, Asfar Ayaz Ghauri, Muhammad Shahzad Shamim

Abstract

Current standard therapy for seizure prophylaxis in Neuro-surgical patients involves the use of Phenytoin (PHY). However, a new drug Levetiracetam (LEV) is emerging as an alternate treatment choice. We aimed to conduct a meta-analysis to compare these two drugs in patients with brain injury.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 132 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 2%
Australia 2 2%
Brazil 1 <1%
Ethiopia 1 <1%
Iran, Islamic Republic of 1 <1%
Spain 1 <1%
Colombia 1 <1%
Unknown 122 92%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 15%
Student > Bachelor 19 14%
Student > Postgraduate 15 11%
Student > Master 14 11%
Other 12 9%
Other 41 31%
Unknown 11 8%
Readers by discipline Count As %
Medicine and Dentistry 87 66%
Pharmacology, Toxicology and Pharmaceutical Science 8 6%
Neuroscience 8 6%
Agricultural and Biological Sciences 4 3%
Nursing and Health Professions 2 2%
Other 6 5%
Unknown 17 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 June 2016.
All research outputs
#2,964,145
of 12,373,815 outputs
Outputs from BMC Neurology
#336
of 1,406 outputs
Outputs of similar age
#26,217
of 119,220 outputs
Outputs of similar age from BMC Neurology
#6
of 21 outputs
Altmetric has tracked 12,373,815 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,406 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 119,220 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.